December 22, 2022 01:07 PM ESTUpdated January 12, 01:28 PM
Financing
Startups
Manufacturing

Start­up mak­ing soft­ware for phar­ma man­u­fac­tur­ing in­dus­try nets $12M+ Se­ries A

Tyler Patchen

News Reporter

Ganymede Bio CEO and co-founder Nathan Clark claims soft­ware for biotechs is 10 to 20 years be­hind oth­er in­dus­tries. His com­pa­ny just re­ceived $12.75 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times